<
https://theconversation.com/hiv-breakthrough-drug-trial-shows-injection-twice-a-year-is-100-effective-against-infection-233295>
"A large clinical trial in South Africa and Uganda has shown that a
twice-yearly injection of a new pre-exposure prophylaxis drug gives young women
total protection from HIV infection.
The trial tested whether the six-month injection of lenacapavir would provide
better protection against HIV infection than two other drugs, both daily pills.
All three medications are pre-exposure prophylaxis (or PrEP) drugs.
Physician-scientist Linda-Gail Bekker, principal investigator for the South
African part of the study, tells Nadine Dreyer what makes this breakthough so
significant and what to expect next."
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
